Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 4776-4782, September 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prochaska, H. J.
Right arrow Articles by Talalay, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prochaska, H. J.
Right arrow Articles by Talalay, P.

Regulatory Mechanisms of Monofunctional and Bifunctional Anticarcinogenic Enzyme Inducers in Murine Liver1

Hans J. Prochaska2 and Paul Talalay3

Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Anticarcinogenic enzyme inducers are of two types: (a) bifunctional inducers [2,3,7,8-tetrachlorodibenzo-p-dioxin, polycyclic aromatics, azo dyes, ß-naphthoflavone] that elevate both Phase II enzymes [e.g., glutathione S-transferases, UDP-glucuronosyltransferases, and NAD(P)H:(quinone-acceptor) oxidoreductase] and certain Phase I enzymes [e.g., aryl hydrocarbon hydroxylase (AHH)]; and (b) monofunctional inducers [e.g., diphenols, thiocarbamates, 1,2-dithiol-3-thiones, isothiocyanates] that elevate primarily Phase II enzymes without significantly affecting AHH. Since Phase I enzymes such as AHH may activate precarcinogens to ultimate carcinogens whereas Phase II enzyme induction suffices to achieve chemoprotection, an understanding of the molecular mechanisms that regulate these enzymes is critical for devising methods for chemoprotection. We report a systematic analysis of the inductions of aryl hydrocarbon hydroxylase (AHH) and NAD(P)H:quinone reductase (QR) by seven monofunctional and eight bifunctional inducers, singly or in combination, in a murine hepatoma cell line (Hepa 1c1c7) and two mutants defective in either Ah (Aryl hydrocarbon) receptor function (BPc1) or in AHH expression (c1). We have also examined such inductions in genetically defined mouse strains with high affinity (C57BL/6J) and low affinity (DBA/2J) Ah receptors. The combination of our earlier model for the induction of Phase I and Phase II enzymes (H. J. Prochaska, M. J. De Long, and P. Talalay, Proc. Natl. Acad. Sci. USA, 82: 8232, 1985) with mechanism(s) for autoregulation of AHH (O. Hankinson, R. D. Anderson, B. W. Birren, F. Sander, M. Negishi, and D. W. Nebert, J. Biol. Chem., 260: 1790, 1985) is compatible with our results. Thus, induction of QR by monofunctional inducers does not depend on a competent Ah receptor or AHH activity and appears to involve an electrophilic chemical signal. In contrast, bifunctional inducers require competent Ah receptors to induce both AHH and QR, although the latter process appears to be regulated by more than one mechanism. It is our view that bifunctional inducers bind to the Ah receptor thereby enhancing transcription of genes encoding both AHH and QR. Metabolizable bifunctional inducers are then converted by the induced AHH to products that resemble monofunctional inducers and are capable of generating the aforementioned chemical signal. The existence of mechanism(s) for AHH autoregulation that also affect Phase II enzyme expression would account for the high basal activities of QR in the AHH-defective mutant (c1).

1 These studies were supported by a Special Institutional Grant (SIG-3) from the American Cancer Society and a grant from the National Cancer Institute, NIH (NIH 1 P01 CA 44530). A preliminary account of these experiments has been published (49).

2 Supported by NCI Training Grant 5T32 CA09243.

3 To whom requests for reprints should be addressed.

Received 2/29/88. Revised 5/17/88. Accepted 5/26/88.




This article has been cited by other articles:


Home page
J Clin PharmacolHome page
L. S. Lee, S. D. Wise, C. Chan, T. L. Parsons, C. Flexner, and P. S. Lietman
Possible Differential Induction of Phase 2 Enzyme and Antioxidant Pathways by American Ginseng, Panax quinquefolius
J. Clin. Pharmacol., May 1, 2008; 48(5): 599 - 609.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. J. Wang, J. D. Hayes, and C. R. Wolf
Generation of a Stable Antioxidant Response Element-Driven Reporter Gene Cell Line and Its Use to Show Redox-Dependent Activation of Nrf2 by Cancer Chemotherapeutic Agents.
Cancer Res., November 15, 2006; 66(22): 10983 - 10994.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. Yoshinari, N. Okino, T. Sato, J. Sugatani, and M. Miwa
INDUCTION OF DETOXIFYING ENZYMES IN RODENT WHITE ADIPOSE TISSUE BY ARYL HYDROCARBON RECEPTOR AGONISTS AND ANTIOXIDANTS
Drug Metab. Dispos., July 1, 2006; 34(7): 1081 - 1089.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. D. Schreiber, C. Kohle, F. Buckler, S. Schmohl, A. Braeuning, A. Schmiechen, M. Schwarz, and P. A. Munzel
REGULATION OF CYP1A1 GENE EXPRESSION BY THE ANTIOXIDANT TERT-BUTYLHYDROQUINONE
Drug Metab. Dispos., July 1, 2006; 34(7): 1096 - 1101.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Lou, S. Du, Q. Ji, and A. Stolz
Induction of AKR1C2 by Phase II Inducers: Identification of a Distal Consensus Antioxidant Response Element Regulated by NRF2
Mol. Pharmacol., May 1, 2006; 69(5): 1662 - 1672.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
W. Schober, B. Belloni, S. Lubitz, B. Eberlein-Konig, P. Bohn, Y. Saritas, J. Lintelmann, G. Matuschek, H. Behrendt, and J. Buters
Organic Extracts of Urban Aerosol (<=PM2.5) Enhance rBet v 1-Induced Upregulation of CD63 in Basophils from Birch Pollen-Allergic Individuals
Toxicol. Sci., April 1, 2006; 90(2): 377 - 384.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Talalay
A Fascination with Enzymes: The Journey Not the Arrival Matters
J. Biol. Chem., August 12, 2005; 280(32): 28829 - 28847.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. E. Moore, W.-Y. Huang, N. Chatterjee, M. Gunter, S. Chanock, M. Yeager, B. Welch, P. Pinsky, J. Weissfeld, and R. B. Hayes
GSTM1, GSTT1, and GSTP1 Polymorphisms and Risk of Advanced Colorectal Adenoma
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1823 - 1827.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. W. P. Devling, C. D. Lindsay, L. I. McLellan, M. McMahon, and J. D. Hayes
Utility of siRNA against Keap1 as a strategy to stimulate a cancer chemopreventive phenotype
PNAS, May 17, 2005; 102(20): 7280 - 7285.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. T. Dinkova-Kostova, K. T. Liby, K. K. Stephenson, W. D. Holtzclaw, X. Gao, N. Suh, C. Williams, R. Risingsong, T. Honda, G. W. Gribble, et al.
Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress
PNAS, March 22, 2005; 102(12): 4584 - 4589.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. H. Andorfer, T. Tchaikovskaya, and I. Listowsky
Selective expression of glutathione S-transferase genes in the murine gastrointestinal tract in response to dietary organosulfur compounds
Carcinogenesis, March 1, 2004; 25(3): 359 - 367.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
V. W.Y. Lui, A. L. Wentzel, D. Xiao, K. L. Lew, S. V. Singh, and J. R. Grandis
Requirement of a carbon spacer in benzyl isothiocyanate-mediated cytotoxicity and MAPK activation in head and neck squamous cell carcinoma
Carcinogenesis, October 1, 2003; 24(10): 1705 - 1712.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W. Miao, L. Hu, M. Kandouz, and G. Batist
Oltipraz Is a Bifunctional Inducer Activating Both Phase I and Phase II Drug-Metabolizing Enzymes via the Xenobiotic Responsive Element
Mol. Pharmacol., August 1, 2003; 64(2): 346 - 354.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. C. Pietsch, J. Y. Chan, F. M. Torti, and S. V. Torti
Nrf2 Mediates the Induction of Ferritin H in Response to Xenobiotics and Cancer Chemopreventive Dithiolethiones
J. Biol. Chem., January 17, 2003; 278(4): 2361 - 2369.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. Talalay and J. W. Fahey
Phytochemicals from Cruciferous Plants Protect against Cancer by Modulating Carcinogen Metabolism
J. Nutr., November 1, 2001; 131(11): 3027S - 3033.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Bonnesen, I. M. Eggleston, and J. D. Hayes
Dietary Indoles and Isothiocyanates That Are Generated from Cruciferous Vegetables Can Both Stimulate Apoptosis and Confer Protection against DNA Damage in Human Colon Cell Lines
Cancer Res., August 1, 2001; 61(16): 6120 - 6130.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
K. L. Henson, G. Stauffer, and E. P. Gallagher
Induction of Glutathione S-transferase Activity and Protein Expression in Brown Bullhead (Ameiurus nebulosus) Liver by Ethoxyquin
Toxicol. Sci., July 1, 2001; 62(1): 54 - 60.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Ramos-Gomez, M.-K. Kwak, P. M. Dolan, K. Itoh, M. Yamamoto, P. Talalay, and T. W. Kensler
From the Cover: Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice
PNAS, March 13, 2001; 98(6): 3410 - 3415.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. P. Hehner, R. Breitkreutz, G. Shubinsky, H. Unsoeld, K. Schulze-Osthoff, M. L. Schmitz, and W. Droge
Enhancement of T Cell Receptor Signaling by a Mild Oxidative Shift in the Intracellular Thiol Pool
J. Immunol., October 15, 2000; 165(8): 4319 - 4328.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A.G. Shepherd, M. M. Manson, H. W.L. Ball, and L. I. McLellan
Regulation of rat glutamate-cysteine ligase ({gamma}-glutamylcysteine synthetase) subunits by chemopreventive agents and in aflatoxin B1-induced preneoplasia
Carcinogenesis, October 1, 2000; 21(10): 1827 - 1834.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Li, M. I. Venkatesan, A. Miguel, R. Kaplan, C. Gujuluva, J. Alam, and A. Nel
Induction of Heme Oxygenase-1 Expression in Macrophages by Diesel Exhaust Particle Chemicals and Quinones via the Antioxidant-Responsive Element
J. Immunol., September 15, 2000; 165(6): 3393 - 3401.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. P. Kelly, E. M. Ellis, M. M. Manson, S. A. Chanas, G. J. Moffat, R. McLeod, D. J. Judah, G. E. Neal, and J. D. Hayes
Chemoprevention of Aflatoxin B1 Hepatocarcinogenesis by Coumarin, a Natural Benzopyrone That Is a Potent Inducer of Aflatoxin B1-Aldehyde Reductase, the Glutathione S-Transferase A5 and P1 Subunits, and NAD(P)H:Quinone Oxidoreductase in Rat Liver
Cancer Res., February 1, 2000; 60(4): 957 - 969.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. Yu, S. Mandlekar, W. Lei, W. E. Fahl, T.-H. Tan, and A.-N. T. Kong
p38 Mitogen-activated Protein Kinase Negatively Regulates the Induction of Phase II Drug-metabolizing Enzymes That Detoxify Carcinogens
J. Biol. Chem., January 28, 2000; 275(4): 2322 - 2327.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Yu, W. Lei, S. Mandlekar, M. J. Weber, C. J. Der, J. Wu, and A.-N. T. Kong
Role of a Mitogen-activated Protein Kinase Pathway in the Induction of Phase II Detoxifying Enzymes by Chemicals
J. Biol. Chem., September 24, 1999; 274(39): 27545 - 27552.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
P. A. Münzel, S. Schmohl, H. Heel, K. Kälberer, B. S. Bock-Hennig, and K. W. Bock
Induction of Human UDP Glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-Butylhydroquinone and 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Caco-2 Cells
Drug Metab. Dispos., May 1, 1999; 27(5): 569 - 573.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
A. T. Dinkova-Kostova and P. Talalay
Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes
Carcinogenesis, May 1, 1999; 20(5): 911 - 914.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Ng, N. Kokot, T. Hiura, M. Faris, A. Saxon, and A. Nel
Macrophage Activation by Polycyclic Aromatic Hydrocarbons: Evidence for the Involvement of Stress-Activated Protein Kinases, Activator Protein-1, and Antioxidant Response Elements
J. Immunol., July 15, 1998; 161(2): 942 - 951.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. J. Henderson, A. G. Smith, J. Ure, K. Brown, E. J. Bacon, and C. R. Wolf
Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases
PNAS, April 28, 1998; 95(9): 5275 - 5280.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Vargas, J. G. Lamb, and M. R. Franklin
Phase II-Selective Induction of Hepatic Drug-Metabolizing Enzymes by Oltipraz [5-(2-Pyrazinyl)-4-methyl-1,2-dithiol-3-thione], 1,7-Phenanthroline, and 2,2'-Dipyridyl in Rats Is Not Accompanied by Induction of Intestinal Enzymes
Drug Metab. Dispos., February 1, 1998; 26(2): 91 - 97.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. W. Fahey, Y. Zhang, and P. Talalay
Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens
PNAS, September 16, 1997; 94(19): 10367 - 10372.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. W. Wasserman and W. E. Fahl
Functional antioxidant responsive elements
PNAS, May 13, 1997; 94(10): 5361 - 5366.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. J. Winner, R. A. Prough, and M. D. Brennan
Human NAD(P)H:Quinone Oxidoreductase Induction in Human Hepatoma Cells after Exposure to Industrial Acrylates, Phenolics, and Metals
Drug Metab. Dispos., February 1, 1997; 25(2): 175 - 181.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
S. G. Kim, S. Y. Nam, C. W. Kim, J. H. Kim, C. K. Cho, and S. Y. Yoo
Enhancement of Radiation-Inducible Hepatic Glutathione-S-Transferases Ya, Yb1, Yb2, Yc1, and Yc2 Gene Expression by Oltipraz: Possible Role in Radioprotection
Mol. Pharmacol., February 1, 1997; 51(2): 225 - 233.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. V. Favreau and C. B. Pickett
The Rat Quinone Reductase Antioxidant Response Element
J. Biol. Chem., October 13, 1995; 270(41): 24468 - 24474.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.